Heart failure due to ischaemic heart disease: Epidemiology, pathophysiology and progression

Journal of Cardiovascular Pharmacology

Volumn 33, Issue SUPPL. 3, 1999, Pages

  Cleland, John G F ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

Author keywords

Aspirin; Heart failure Ischaemic heart disease; Statin

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; AMLODIPINE; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; BUCINDOLOL; CALCIUM ANTAGONIST; CARVEDILOL; DIGITALIS; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FELODIPINE; HYDRALAZINE; METOPROLOL; NITRATE; OXPRENOLOL; PLACEBO; SIMVASTATIN; SOTALOL; STATIN; THIAZIDE DIURETIC AGENT; TIMOLOL;

CLINICAL TRIAL; CONFERENCE PAPER; CORONARY ARTERY DISEASE; HEART FAILURE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; META ANALYSIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ANIMALS; DISEASE PROGRESSION; HEART FAILURE, CONGESTIVE; HUMANS; MYOCARDIAL ISCHEMIA; PROGNOSIS;

EID: 0032813343     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199906003-00003     Document Type: Conference Paper

References (4)

1. Pitt B, Segal R, Martinez FA, et al., on behalf of the ELITE study group. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly study, ELITE). Lancet 1997;349:747-752.
2. Packer M, Bristow MR, Cohn JN, et al., for the US carvedilol study group. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996;334:1349-1355.
3. Cleland JGF. Screening for left ventricular dysfunction and heart failure: should it be done and if so how? Dis Management Health Outcomes 1997;1:169-184.
4. McDonagh TA, Morrison CE, Lawrence A, et al. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet 1997;350:829-833.